Neuropsychological Tests
10
2
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Brain Stimulation for Concussion
Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients
Vanderbilt Memory and Aging Project
Screening for Cognitive Disorders in Multiple Sclerosis
Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language
Perioperative IL-33 is Associated with the Early Stage of Postoperative Neurocognitive Dysfunction After Major Abdominal Surgery
Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)
Remote Cognitive Multidomain Assessment in People With Cognitive Disorders
Rhythmically Entrained Exercise in Community-Dwelling Older Adults
The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients